Social Media Usage in Adolescent Girls

NCT06426459 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2024-05-23

No results posted yet for this study

Summary

The study aims to explore the effects of hormonal fluctuations throughout the menstrual cycle on social media use, brain architecture, neural reward processing and reward behavior, and affective status in adolescent girls. Additionally, it strives to compare the effects of exogenous and endogenous hormones on the above-mentioned aspects. For this purpose, the investigators will compare two main groups in the study: 1. Naturally cycling adolescent girls, 2. Adolescent girls using combined oral contraceptives. This study will combine self-report data via questionnaires, ecological data via Ecological Momentary Assessment (EMA), endocrine data via blood collection, and neural data via fMRI assessment to enhance the understanding of the neurobiological mechanisms underlying social media use in adolescent girls. Furthermore, it seeks to elucidate whether there are vulnerable periods throughout the menstrual cycle when adolescent girls are especially prone to dysfunctional social media use and help to design more specific interventions as well as therapy.

Conditions

  • Menstrual Cycle
  • Oral Contraceptive

Sponsors & Collaborators

  • German Research Foundation

    collaborator OTHER
  • University Hospital Tuebingen

    collaborator OTHER
  • Uppsala University

    collaborator OTHER
  • International Research Training Group 2804

    lead OTHER

Principal Investigators

  • Tobias Renner, Prof. Dr. med. · Child Psychiatry, University Clinic Tübingen

  • Tomas Furmark, Dr. · Department of Psychology, Uppsala University, Sweden

Eligibility

Min Age
15 Years
Max Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-29
Primary Completion
2025-12-01
Completion
2026-03-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06426459 on ClinicalTrials.gov